申请人:Paratek Pharmaceuticals, Inc.
公开号:US20150045329A1
公开(公告)日:2015-02-12
The present invention pertains, at least in part, to novel substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for tetracycline compounds such as blocking tetracycline efflux and modulation of gene expression.